News | July 30, 2009

GE's Biopsy-Enabled Mammography Platform to Demo at BIC

July 30, 2009 - The Senographe Essential Interventional is an add-on digital stereotaxy option on the company’s innovative Senographe Essential digital mammography platform, which it will show at the Breast Imaging Conference (BIC), held Sept. 15-17, in Glendale, Ariz.
The Senographe Essential Interventional lets users perform biopsies without a dedicated biopsy room. The add-on solution enables technologists to quickly transition from initial screening applications to diagnostics, and if needed, to interventional procedures, all in one room.

The Senographe Essential provides a large field-of-view, which means it can accommodate a diverse range of patient shapes and sizes – all with reportedly high-image quality due to GE’s innovative digital flatpanel detector with high Detective Quantum Efficiency (DQE).
The Senographe Essential is designed to allow clinicians’ with easy localization of lesions and a consistency in image quality for diagnosis and biopsy. Once pinpointed, the new system allows for vertical and lateral approach in accessing the lesion, helping to improve overall efficiency and patient comfort while maintaining clinical confidence.

For more information;

Related Content

News | Biopsy Systems | March 29, 2019
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy...
FDA Clears Ion Endoluminal Lung Biopsy System
Technology | Interventional Radiology | February 20, 2019
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...